PetMed Express, Inc. (PETS) Financials
PETS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 63.8 million | 40.8 million |
| March 31, 2026 | 81.2 million | 52.3 million |
| Dec. 31, 2025 | 88.0 million | 55.2 million |
| Sept. 30, 2025 | 100.3 million | 57.2 million |
PETS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -8.3 million | 198000 |
| March 31, 2026 | -5.5 million | 272000 |
| Dec. 31, 2025 | -9.2 million | 254000 |
| Sept. 30, 2025 | -4.8 million | 248000 |
PETS Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -6.1 million |
| March 31, 2026 | -4.1 million |
| Dec. 31, 2025 | -10.6 million |
| Sept. 30, 2025 | -8.5 million |
PETS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 13.1 million | - | - |
| March 31, 2026 | 21.4 million | - | 535000 |
| Dec. 31, 2025 | 26.9 million | - | 652000 |
| Sept. 30, 2025 | 36.1 million | - | 768000 |
PETS Shares Outstanding
PETS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 641000 | - | 11.2 million | 4.2 million |
| March 31, 2026 | 720000 | - | 11.4 million | 5.8 million |
| Dec. 31, 2025 | 21000 | - | 12.2 million | 5.3 million |
| Sept. 30, 2025 | 2.6 million | - | 14.2 million | 4.3 million |
PETS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 41.0 million | 29.7 million |
| March 31, 2026 | 42.8 million | 36.0 million |
| Dec. 31, 2025 | 40.7 million | 31.2 million |
| Sept. 30, 2025 | 44.4 million | 31.9 million |
PETS
Price: $1.81
52 week price:
Payout Ratio: -923.08%
Payout Ratio Range:
Earnings Per Share: -1.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Pharmaceutical Retailers
Country: United States
Volume: 271900
Ebitda: 12.0 millionMarket Capitalization: 38.4 million
Average Dividend Frequency: 4